SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 8th, 2024 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 2, 2024, is by and among Windtree Therapeutics, Inc., a Delaware corporation with offices located at 2600 Kelly Road, Suite 100, Warrington, PA 18976 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 8th, 2024 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances)
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 2, 2024, is by and among Windtree Therapeutics, Inc., a Delaware corporation with offices located at 2600 Kelly Road, Suite 100, Warrington, PA 18976 (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
ASSET PURCHASE AGREEMENT between VARIAN BIOPHARMACEUTICALS, INC. and WINDTREE THERAPEUTICS, INC. Dated April 2, 2024Asset Purchase Agreement • April 8th, 2024 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
THIS ASSET PURCHASE AGREEMENT, dated as of April 2, 2024 (the “Closing Date”), is made and entered into between Varian Biopharmaceuticals, Inc., a Delaware corporation (“Seller”) and Windtree Therapeutics, Inc., a Delaware corporation (“Buyer”).
